BaumanMedical.com
Hair Loss on Good Morning America


Tune in tomorrow...  Friday, May 6th to

ABC's Good Morning America

 



"Hair Loss Breakthroughs"

 

Dr. Alan Bauman is scheduled to discuss the latest treatments and procedures like LaserCap, NeoGraft FUE hair transplantation, "82M" Minoxidil as well as other new topical treatments like Latisse/Bimatoprost on ABC Good Morning America.   

Check your local listings for showtimes. 


NEW VIDEO:  

Latisse for Scalp Hair



Bauman patient, Rich P. wanted to Dr. Bauman on NBC Miami South Florida TODAY Show
slow the progression of his hair loss, but without using Propecia or minoxidil. After hearing that Allergan has begun clinical trials, Rich decided to try Latisse(bimatoprost) --the medication for eyelash growth--on his scalp!  Watch this new video from WSVN Miami to see how he responded to the treatment.

Yesterday, the New York Times mentioned Latisse as one of the potential new strategies to fight hair loss.  Dr. Bauman was interviewed regarding Latisse and other advanced treatments.  Read the NY Times story.  

For more information on off-label treatments and cutting edge procedures, visit www.baumanmedical.com
NEW VIDEO:
Propecia Study Contradicts Doctors' Experiences


Watch the Interview on NBC6A recent published report contradicts our long-term experience with thousands of patients over 15 years! Propecia side effects are rare and reversible. What is the real incidence of Propecia side-effects? Are they reversible or persistent? What are the alternatives to Propecia?  Watch the video to find out!

At Bauman Medical Group we specialize in helping men and women with hair loss maintain, enhance and restore their own living and growing hair. FDA-approved Propecia may only be part of the solution. High-powered compounded minoxidil, like 82M in addition to the portable and convenient LaserCap for at-home laser therapy can also help. If necessary, no-scalpel/no-stitch NeoGraft FUE hair transplants restore hair without a linear scar and with less discomfort and less downtime. Email Dr. Alan Bauman to find out what's right for you...

LaserCap:  Powerful and Discreet    
Watch LaserCap results video
LaserCap is the most powerful, most portable, most convenient and most discreet way to apply laser therapy to the scalp anywhere, anytime. Laser therapy, like other non-invasive treatment options, enhances hair growth in areas where hair follicles still exist.  For thicker, healthier and fuller looking hair using laser therapy without the hand-held hassle or in-office clinic visit, consider LaserCap.

NeoGraft FUE is Ideal for Athletes  

 

No Scalpel / No Stitch FUE using NeoGraft
NeoGraft FUE, the least invasive hair transplant available, allows the harvesting of hair follicles without leaving behind a linear scar. With a quicker and more comfortable recovery, you can return to regular activities sooner. Want to get back to the gym? Athletic workouts can begin as early as three days after your procedure because there are no stitches or wounds to stretch. This photo (right) shows the healing of the scalp at day#1 and day#7.

 

 April 2011
In This Issue
Latisse for Scalp Hair
Propecia Side-Effects
LaserCap Results
NeoGraft for Athletes

Connect with
Alan J. Bauman, M.D.

Alan J. Bauman, M.D.
Find me on Facebook
View my profile on LinkedInFollow me on Twitter
View my videos on YouTube
Visit my blog
View my photos on flickr

RESULTS speak for themselves... see a slideshow of Dr. Bauman's results.


Find us on Facebook
Visit Bauman Medical Group's official Facebook page for special offers and announcements!
Join Our Mailing List
Want Thicker, Fuller, Healthier Looking Hair? 
Helping men and women medically enhance, maintain and restore their own living and growing hair since 1997.

Alan J. Bauman, M.D.
Bauman Medical Group, P.A.
1-561-394-0024 or 1-877-BAUMAN-9 toll free
© Copyright 2011. Bauman Medical Group, P.A.
All rights reserved. 

*Restrictions Apply. Enrollment is limited. Qualified candidates for the trial will receive free evaluation and treatment during the course of the 12-week trial.